ExLibris header image
SFX Logo
Title: Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes
Source:

Journal of Medicinal Chemistry [0022-2623] Satoshi Mikami, Shuji yr:2012


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Momose, Tsuneo u. "Optimization of (2,3-Dihydro-1-Benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent." Journal of medicinal chemistry 55.8 (2012): 3960-3974. Link to Full Text for this item Link to SFX for this item
2. Li, Z. "Design, synthesis and Structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes." European journal of medicinal chemistry 113 (2016): 246-257. Link to SFX for this item
3. Mohareb, R M. "Reaction of 2‐amino‐3‐cyano‐4, 5, 6, 7‐tetrahydrobenzo‐[b] thiophene with ethyl acetoacetate: Novel syntheses of pyridines, pyrazoles, and their fused derivatives." Heteroatom chemistry 12.6 (2001): 518-. Link to SFX for this item
4. Negoro, N. "Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists." Journal of medicinal chemistry 55.4 (2012): 1538-1552. Link to Full Text for this item Link to SFX for this item
5. Negoro, N. "Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist." ACS medicinal chemistry letters 1.6 (2010): 290-294. Link to Full Text for this item Link to SFX for this item
6. Burant, Charles F. "Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes." Diabetes care 36 Suppl 2.S2 (2013): -9. Link to SFX for this item
7. "Ácidos grasos en la dieta diabetes mellitus e insulino resistencia." Revista de la Facultad de Medicina. 54.2: 134-142. Link to SFX for this item
8. Upur, Z. "A study of the law of herbal administration in treating lung-distension by TCM physicians through history using cluster analysis." Journal of traditional chinese medicine 31.4 (2011): 303-7. Link to SFX for this item
9. Zhang, S. "Synthesis and blocking activities of isoindolinone- and isobenzofuranone-containing phenoxylalkylamines as potent α1-adrenoceptor antagonists." Chemical and Pharmaceutical Bulletin 59.1 (2011): 96-99. Link to SFX for this item
10. Mayhoub, Abdelrahman S. "Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets." Bioorganic & medicinal chemistry 20.1 (2012): 510-520. Link to SFX for this item
11. Houze, J. "AMG 837: A potent, orally bioavailable GPR40 agonist." Bioorganic and medicinal chemistry letters 22.2 (2012): 1267-1270. Link to SFX for this item
12. Alexander, S. "G PROTEIN-COUPLED RECEPTORS." British Journal of Pharmacology 164.s1 (2011): 5-113. Link to Full Text for this item Link to SFX for this item
13. Tsujihata, K. "TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats." The journal of pharmacology and experimental therapeutics 339.1 (2011): 228-237. Link to SFX for this item
14. Vorogushin, Andrei V. "Stereoselectivity of the Benzannulation Reaction: Efficient Central-to-Axial Chirality Transfer." Journal of the American Chemical Society 124.23 (2002): 6512-6513. Link to Full Text for this item Link to SFX for this item
15. Matsuya, Y. "Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic." Bioorganic & medicinal chemistry 15.1 (2007): 424-432. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced